<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03046836</url>
  </required_header>
  <id_info>
    <org_study_id>54689</org_study_id>
    <nct_id>NCT03046836</nct_id>
  </id_info>
  <brief_title>Oxytocin, Alcohol Craving, and Intimate Partner Aggression</brief_title>
  <official_title>Effects of Oxytocin on Alcohol Craving and Intimate Partner Aggression</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Medical University of South Carolina</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Medical University of South Carolina</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>Yes</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Alcohol use disorders (AUD) and intimate partner aggression (IPA) frequently co-occur. There
      are significant health and economic burdens associated with AUD and co-occurring IPA, and
      little empirical data to guide treatment efforts. The neuropeptide oxytocin may help mitigate
      both AUD and IPA. However, clinical data examining oxytocin's effects on human aggression is
      scant. The proposed study is designed to address these gaps in the literature by utilizing a
      human laboratory paradigm to test the effects of oxytocin on craving and aggression among
      couples with AUD and co-occurring IPA.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 1, 2017</start_date>
  <completion_date type="Anticipated">May 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2020</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Factorial Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Alcohol Craving</measure>
    <time_frame>2 hours</time_frame>
    <description>Subjective alcohol craving Measured on a Likert-type scale of 1-10</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Cortisol</measure>
    <time_frame>2 hours</time_frame>
    <description>Salivary cortisol</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Aggression</measure>
    <time_frame>2 hours</time_frame>
    <description>Laboratory-based aggression paradigm</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Alcohol Use</condition>
  <arm_group>
    <arm_group_label>Oxytocin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Each participant will self-administer 40 IU intranasal Oxytocin</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Each participant will self-administer matching saline placebo</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Oxytocin</intervention_name>
    <description>40 IU oxytocin nasal spray</description>
    <arm_group_label>Oxytocin</arm_group_label>
    <other_name>Pitocin</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo</intervention_name>
    <description>Saline</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Inclusion criteria indicate that participants must

          -  aged 18 or over

          -  fluent in English

          -  endorse at least one instance of mild or moderate physical IPA with their partner in
             the past 6 months as defined by the Revised Conflict Tactics Scale (CTS-2)

          -  both partners must be willing to participate

          -  one or both partners must meet DSM-V diagnostic criteria for an alcohol use disorder
             (AUD). Concurrent substance use disorders (e.g., marijuana) is acceptable provided
             alcohol is the participant's primary substance of choice.

        Exclusion Criteria:

          -  Exclusion criteria include

          -  pregnancy or breastfeeding

          -  current or history of psychiatric or medical condition that could interfere with
             neuroendocrine function (e.g., hematological, endocrine, renal, or pulmonary disease;
             synthetic glucocorticoid or exogenous steroid therapy; psychotic, bipolar, eating
             disorders)

          -  BMI â‰¥ 39

          -  current suicidal ideation and intent

          -  severe physical or sexual IPA in the past six months as defined by the CTS-2

          -  initiation of psychotropic medication in the past 4 weeks

          -  acute alcohol withdrawal as indicated by a score of 8 or greater on the CIWA-Ar.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Julianne C Flanagan, Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Medical University of South Carolina</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Julianne C Flanagan, Ph.D.</last_name>
    <phone>843-792-5569</phone>
    <email>Hellmuth@musc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Medical University of South Carolina</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29425</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sudie E. Back, Ph.D.</last_name>
      <phone>843-792-9383</phone>
      <email>backs@musc.edu</email>
    </contact>
    <investigator>
      <last_name>Megan Moran-Santa Maria, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Julianne C. Flanagan, Ph.D.</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>September 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 3, 2017</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2017</study_first_posted>
  <last_update_submitted>September 25, 2017</last_update_submitted>
  <last_update_submitted_qc>September 25, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">September 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Medical University of South Carolina</investigator_affiliation>
    <investigator_full_name>Julianne Flanagan</investigator_full_name>
    <investigator_title>Assistant Professor</investigator_title>
  </responsible_party>
  <keyword>Couples</keyword>
  <keyword>Oxytocin</keyword>
  <keyword>Aggression</keyword>
  <keyword>Alcohol</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Aggression</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ethanol</mesh_term>
    <mesh_term>Oxytocin</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

